HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
01-01-2018
-30-09-2022
Show more information
Organisation
ICON CLINICAL RESEARCH (U.K.) LIMITED